[Historical retrospective. Lipamin (Agomensin) and luteolipoid (Sistomensin). Animal experiments and preliminary clinical experiences].
In 1914 "Lipamin" and "Luteolipoid", two extracts of corpus luteum, were developed at the University Gynaecological Hospital in Erlangen, Bavaria. The process of their preparation, protected by patents, was exploited soon after that by Ciba, Basel, who named their products Agomensin and Sistomensin. The history of their development, their effects in animal experiments, as well as their early therapeutical application to women are reported. Special reference is made to the patent specifications and to the lectures held at meetings of the Bavarian Society of Gynaecology and Obstetrics.
Süss
J
J
Simmer
H H
HH
D000818:Animals; D003338:Corpus Luteum / Q000032:analysis*; D045166:Estradiol Congeners / Q000266:history*; D005260:Female; D005858:Germany; D049672:History, 19th Century; D049673:History, 20th Century; D006801:Humans; D008599:Menstruation Disturbances / Q000266:history*; D045167:Progesterone Congeners / Q000266:history*; D011817:Rabbits; D014020:Tissue Extracts / Q000266:history*
D045166:Estradiol Congeners; D045167:Progesterone Congeners; D014020:Tissue Extracts
Der Historische Rückblick. Lipamin (Agomensin) und Luteolipoid (Sistomensin). Tierexperimente und die vermeintliche klinische Erfahrung.